Recent Updates
Recently added Catalysts
INDV Positive Sentiment Score: 65/100

Indivior to Participate in Upcoming Investor Events Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate in the following investor events: Jefferies Global Healthcare Conference –...

Key Takeaway: Indivior PLC has announced its participation in several investor events scheduled for June 2025. CEO Joe Ciaffoni and CFO Ryan Preblick will host meetings and discussions, enhancing investor engagement. The company emphasizes its commitment to addressing substance use disorders through innovative treatments and a strong product pipeline.

Market Sentiment Analysis

POSITIVE FACTORS

  • Indivior is actively engaging with investors through multiple events.
  • The CEO will be involved in a public fireside chat, increasing visibility.
  • Indivior's dedication to treating substance use disorders highlights its commitment to a significant public health issue.

Full Press Release Details

RICHMOND, Va. , May 13, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate in the following investor events:
Joe Ciaffoni , Chief Executive Officer, and Ryan Preblick , Chief Financial Officer, will host 1x1 / group meetings on Wednesday, June 4 th . Joe Ciaffoni will also participate in a fireside discussion on Wednesday, June 4 th at 9:55 a.m. U.S. ET. Interested investors should contact their Jefferies representative to schedule a meeting. The fireside discussion will be publicly available and can be viewed using the following weblink:
Joe Ciaffoni , Chief Executive Officer, and Ryan Preblick , Chief Financial Officer, will host 1x1 / group meetings on Wednesday, June 11 th . Interested investors should contact their Goldman Sachs representative to schedule a meeting.
Joe Ciaffoni , Chief Executive Officer, and Ryan Preblick , Chief Financial Officer, will host 1x1 / group meetings virtually on Wednesday, June 25 th . Interested investors should contact their Northland representative to schedule a meeting.
About Indivior Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD). Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond , VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior .
SOURCE Indivior PLC

21 %

Frequently Asked Questions

When will Indivior host investor meetings?

Indivior will host investor meetings on June 4, June 11, and June 25, 2025.

Who are the key speakers at Indivior's events?

Joe Ciaffoni, CEO, and Ryan Preblick, CFO, will be the key speakers.

How can investors schedule meetings with Indivior?

Investors should contact their Jefferies, Goldman Sachs, or Northland representatives.

What is Indivior's main focus?

Indivior focuses on developing medicines for substance use disorders.

Where is Indivior headquartered?

Indivior is headquartered in Richmond, Virginia, USA.

Last updated: May 13, 2025